Skip to main content
. Author manuscript; available in PMC: 2022 Jun 15.
Published in final edited form as: Small Methods. 2021 Apr 22;5(6):2100197. doi: 10.1002/smtd.202100197

Table 2.

A list of initial values.

Parameter Description Value Source
nG(0) *Initial density of tumor cell (2×104 cell·mm−3) 1 Set as normalization unit
nm1(0)+nm2(0) *Initial density of TAM 2 Experimental
n T,total *Amount of T cell added to blood vessel converted to density in TME 30 Experimental
n T *Estimated density of extravasated CD8+ T cell into TME by integral of Eq. (6) (clinically, the density of CTLs in TME) Dual/CSF-1R inhibition for all patients: 8
PD-1 inhibition/Control:
Patient 1: 5.101
Patient 2: 5.646
Patient 3: 5.723
Patient 4: 3.718
Patient 5: 4.213
Patient 6: 5.864
Patient 7: 6.054
Patient 8: 2.507
Patient 9: 5.486
Fitted with experimental data
cCSF1nG(0)KCSF1(R) *The concentration of CSF-1 secreted by tumor, normalized with cell density and the CSF-1 concentration for half-maximal activation of CSF-1(R) pathway. Deduced from the patient-various M2 TAM Patient 1: 7.375
Patient 2: 5.453
Patient 3: 5.210
Patient 4: 16.746
Patient 5: 13.069
Patient 6: 5.359
Patient 7: 4.736
Patient 8: 32.717
Patient 9: 6.716
Experimental